These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32476815)

  • 1. Review: Role of cAMP signaling in diabetic retinopathy.
    Steinle JJ
    Mol Vis; 2020; 26():355-358. PubMed ID: 32476815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovascular regulation in diabetic retinopathy and emerging therapies.
    Ji L; Tian H; Webster KA; Li W
    Cell Mol Life Sci; 2021 Aug; 78(16):5977-5985. PubMed ID: 34230991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.
    Romero-Aroca P; Baget-Bernaldiz M; Pareja-Rios A; Lopez-Galvez M; Navarro-Gil R; Verges R
    J Diabetes Res; 2016; 2016():2156273. PubMed ID: 27761468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
    Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
    Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unfolded protein response and diabetic retinopathy.
    Ma JH; Wang JJ; Zhang SX
    J Diabetes Res; 2014; 2014():160140. PubMed ID: 25530974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of microRNAs in activating neovascularization pathways in diabetic retinopathy.
    Satari M; Aghadavod E; Mirhosseini N; Asemi Z
    J Cell Biochem; 2019 Jun; 120(6):9514-9521. PubMed ID: 30556195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between microRNAs expression and signaling pathways of inflammatory markers in diabetic retinopathy.
    Shafabakhsh R; Aghadavod E; Mobini M; Heidari-Soureshjani R; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):7781-7787. PubMed ID: 30478931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
    Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
    Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
    Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
    Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Retinopathy: From Animal Models to Cellular Signaling.
    Pitale PM; Gorbatyuk MS
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNAS-modulators of neurovascular units in diabetic retinopathy.
    Pu S; Xu Y; Li X; Yu Z; Zhang Y; Tong X; Shan Y; Gao X
    Eur J Pharmacol; 2022 Jun; 925():174937. PubMed ID: 35430212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis.
    Yu Y; Yang L; Lv J; Huang X; Yi J; Pei C; Shao Y
    Int J Clin Exp Pathol; 2015; 8(6):6807-13. PubMed ID: 26261566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy.
    Pfeifer CW; Walsh JT; Santeford A; Lin JB; Beatty WL; Terao R; Liu YA; Hase K; Ruzycki PA; Apte RS
    Proc Natl Acad Sci U S A; 2023 Nov; 120(45):e2308214120. PubMed ID: 37903272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets.
    Gardner TW; Antonetti DA; Barber AJ; LaNoue KF; Nakamura M
    Diabetes Technol Ther; 2000; 2(4):601-8. PubMed ID: 11469624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Adenosinergic System in Diabetic Retinopathy.
    Vindeirinho J; Santiago AR; Cavadas C; Ambrósio AF; Santos PF
    J Diabetes Res; 2016; 2016():4270301. PubMed ID: 27034960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE plays key role in diabetic retinopathy: a review.
    Lu Z; Fan B; Li Y; Zhang Y
    Biomed Eng Online; 2023 Dec; 22(1):128. PubMed ID: 38115006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
    Mol Vis; 2018; 24():394-406. PubMed ID: 29853773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy.
    Yokomizo H; Maeda Y; Park K; Clermont AC; Hernandez SL; Fickweiler W; Li Q; Wang CH; Paniagua SM; Simao F; Ishikado A; Sun B; Wu IH; Katagiri S; Pober DM; Tinsley LJ; Avery RL; Feener EP; Kern TS; Keenan HA; Aiello LP; Sun JK; King GL
    Sci Transl Med; 2019 Jul; 11(499):. PubMed ID: 31270273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acids in prevention of diabetic retinopathy.
    Behl T; Kotwani A
    J Pharm Pharmacol; 2017 Aug; 69(8):946-954. PubMed ID: 28481011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy.
    Deliyanti D; Alrashdi SF; Touyz RM; Kennedy CR; Jha JC; Cooper ME; Jandeleit-Dahm KA; Wilkinson-Berka JL
    Hypertension; 2020 Apr; 75(4):1091-1101. PubMed ID: 32114846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.